Application Information

This drug has been submitted to the FDA under the reference 022141/001.

Names and composition

"LAMIVUDINE; TENOFOVIR DISOPROXIL FUMARATE" is the commercial name of a drug composed of LAMIVUDINE and TENOFOVIR DISOPROXIL FUMARATE.

Forms

ApplId/ProductId Drug name Active ingredient Form Strenght
022141/001 LAMIVUDINE; TENOFOVIR DISOPROXIL FUMARATE LAMIVUDINE; TENOFOVIR DISOPROXIL FUMARATE TABLET/ ORAL 300MG and 300MG
022344/001 LAMIVUDINE; TENOFOVIR DISOPROXIL FUMARATE LAMIVUDINE; TENOFOVIR DISOPROXIL FUMARATE TABLET/ ORAL 300MG and 300MG
200623/001 LAMIVUDINE; TENOFOVIR DISOPROXIL FUMARATE LAMIVUDINE; TENOFOVIR DISOPROXIL FUMARATE TABLET/ ORAL 300MG and 300MG
202529/001 LAMIVUDINE; TENOFOVIR DISOPROXIL FUMARATE LAMIVUDINE; TENOFOVIR DISOPROXIL FUMARATE TABLET/ ORAL 300MG and 300MG
203283/001 LAMIVUDINE; TENOFOVIR DISOPROXIL FUMARATE LAMIVUDINE; TENOFOVIR DISOPROXIL FUMARATE TABLET/ ORAL 300MG and 300MG

Similar Active Ingredient

ApplId/ProductId Drug name Active ingredient Form Strenght
022141/001 LAMIVUDINE; TENOFOVIR DISOPROXIL FUMARATE LAMIVUDINE; TENOFOVIR DISOPROXIL FUMARATE TABLET/ ORAL 300MG and 300MG
022344/001 LAMIVUDINE; TENOFOVIR DISOPROXIL FUMARATE LAMIVUDINE; TENOFOVIR DISOPROXIL FUMARATE TABLET/ ORAL 300MG and 300MG
200623/001 LAMIVUDINE; TENOFOVIR DISOPROXIL FUMARATE LAMIVUDINE; TENOFOVIR DISOPROXIL FUMARATE TABLET/ ORAL 300MG and 300MG
202529/001 LAMIVUDINE; TENOFOVIR DISOPROXIL FUMARATE LAMIVUDINE; TENOFOVIR DISOPROXIL FUMARATE TABLET/ ORAL 300MG and 300MG
203283/001 LAMIVUDINE; TENOFOVIR DISOPROXIL FUMARATE LAMIVUDINE; TENOFOVIR DISOPROXIL FUMARATE TABLET/ ORAL 300MG and 300MG
207315/001 LAMIVUDINE AND TENOFOVIR DISOPROXIL FUMARATE LAMIVUDINE; TENOFOVIR DISOPROXIL FUMARATE TABLET/ORAL 75MG and 75MG

Ask a doctor

A licensed doctor will try to answer your question for free as quickly as possible. Free of charge during the beta period.

Related

Browse by letter
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

© Medications.li 2015-2017 - All rights reserved